What's New at Charles River
   
 
 
   
   

Discovery PK Now Offered at Charles River Massachusetts

January 31, 2011 - Our Preclinical Services facility at Charles River headquarters in Wilmington, MA, now provides rapid non-GLP pharmacokinetic (PK) screening studies to assist our sponsors in lead candidate selection from libraries of compounds. Our high-throughput bioavailability screening includes formulation, in vivo, small molecule bioanalytical and PK and toxicokinetic reporting services. Our experienced team is fully capable of perfoming discovery PK screening in rodent and nonrodent species.

We provide the following benefits to customers seeking non-GLP PK screening:

  • Ability to meet aggressive timelines for outsourced PK programs
  • Short lead time for study initiation (study starts within five to seven days of inquiry)
  • Rapid turnaround times on in-life and bioanalytical studies (five to seven business days from receipt of test articles to submission of report, including PK calculations on bioanalytical data)
  • Flexible scheduling to allow last-minute changes to study protocol
  • Standardized, abbreviated protocols and reporting methods


For more information on our discovery PK screening services, click here or contact us at askcharlesriver@crl.com.

   
Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
Jan 31 - Discovery PK Now Offered at Charle...
Mar 01 - Drug Discovery & Development: PET ...
May 14 - New Models for Evaluating COPD or ...
Jun 17-Jun 20 -  Noordwijk aan Zee, the Netherlands - 19th MDO Meeting / 12th European ...
Jun 02-Jun 05 - Vancouver, British Columbia - CALAS
Jun 05-Jun 05 - King of Prussia, Pennsylvania - Assessment of Immunomodulation for Biol...
Jun 05-Jun 08 - Saint Germain sur l’Arbresle, France - Charles River LAL Seminar Series
view all
Scientist I Wilmington, MA
Manager International Tax Wilmington, MA

Charles River Laboratories, Inc.